MCL1 and B-cell chronic lymphocytic leukemia: Since inhibition of MCL1 is effective in CLL cells and the MCL1 antagonist, AMG-176, has been demonstrated to induce apoptosis in the CLL setting (36), we wanted to evaluate if AMG-176 could impair Kyn-mediated survival of CLL cells.